期刊文献+

血清髓过氧化物酶和高敏C反应蛋白与冠状动脉粥样硬化的相关性研究 被引量:5

The correlation of serum myeloperoxidase and high sensitivity Creactive protein with coronary artery atherosclerosis
下载PDF
导出
摘要 目的探讨血清髓过氧化物酶(MPO)和高敏C反应蛋白(hs-CRP)在冠状动脉粥样硬化不同程度中的变化。方法应用酶联免疫吸附试验(ELISA)测定67例经冠状动脉造影证实的冠心病患者和20例造影阴性对照者的MPO水平,冠心病患者按造影结果分为3组。用免疫透射比浊测定hs-CRP,同时检测血清中的总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)的水平以及白细胞(WBC)计数等指标。结果造影阴性组MPO水平为(4.53±1.26)U/mL,病例组中狭窄程度≤50%为(4.35±1.12)U/mL,50%<狭窄程度≤75%为(3.57±0.77)U/mL,狭窄程度>75%为(2.92±0.47)U/mL。除狭窄程度≤50%组外,其他病例组血清MPO水平均显著低于造影阴性组。hs-CRP则与之相反。MPO水平与WBC计数呈正相关(r=0.389,P=0.003)。结论MPO在血清中的低水平表达可作为冠状动脉粥样硬化的危险因子,是独立于hs-CRP的炎症标志物。 Objective To investigate the changes of serum myeloperoxidase (MPO) and high sensitivity C-reactive protein (hs-CRP) in coronary artery atherosclerosis. Methods The serum levels of MPO were determined by enzymelinked immunosorbent assay (ELISA) in 67 patients diagnosed as coronary artery atherosclerosis by angiography and 20 cases which angiography was normal as control group. The patients were divided into three groups according to angiography result. Immuno-turbidimetry was applied to measure the level of serum hs-CRP. Total cholesterol, triglyceride,low density lipoprotein cholesterol,high density lipoprotein cholesterol and white blood cell (WBC) count were measured. Results The serum level of MPO in stenosis group were significantly lower than in control group,except patients which degree of vascular stenosis ≤〈50%. The level of MPO in patient with angiography negative was (4.53 ± 1.26)U/mL; the patient with the degree of vascular stenosis ≤50% was (4.35 ± 1.12) U/mL;the patient with the degree of vascular stenosis 50% - 75% was (3.57 ± 0.77) U/mL; the patient with the degree of vascular stenosis 〉 75% was (2.92 ± 0. 47) U/mL. The serum levels of MPO were not correlated with hs-CRP but positively correlated with WBC count (r =0. 389,P = 0. 003 ). Conclusions The low expression of MPO in serum may be a risk factor of coronary artery atherosclerosis and it is an inflammation marker independent of hs-CRP.
出处 《检验医学》 CAS 北大核心 2007年第2期179-181,共3页 Laboratory Medicine
关键词 髓过氧化物酶 高敏C反应蛋白 冠状动脉粥样硬化 Myeloperoxidase High sensitivity C-reactive protein Coronary artery atherosclerosis
  • 相关文献

参考文献8

  • 1马庆华,张钲,王恒大.髓过氧化物酶与急性冠脉综合征[J].国外医学(心血管疾病分册),2005,32(1):26-28. 被引量:5
  • 2刘艳玲,吴健民.冠心病患者中性粒细胞氧化代谢指标的检测及意义[J].中华检验医学杂志,2003,26(7):407-410. 被引量:2
  • 3曹平良,葛郁芝,盛国泰,邱元芝,李年娥.髓过氧化物酶和超敏C反应蛋白在冠心病中的对比研究[J].中国心血管病研究,2005,3(9):651-652. 被引量:4
  • 4Brennan ML,Anderson M,Shih DM,et al.Increased atherosclerosis in myeloperoxidase-deficient mice[J].J Clin Invest,2001,107(4):419-430.
  • 5Daugherty A,Dunn JL,Rateri DL,et al.Serum myeloperoxidase and high sensitivity c-reactive protein and their correlations with coronary atherosclerosis[J].J Clin Invest,1994,94(1):437-444.
  • 6Bekesi G,Kakucs R,Sandor J,et al.Plasma concentration of myeloperoxidase enzyme in pre-and post-climacterial people:related superoxide anion generation[J].Exp Gerontol,2001,37(1):137-148.
  • 7Malle E,Marsche G,Panzenboeck U.Myeloperoxidase-mediated oxidation of high -density lipoproteins:fingerprints of newly recognized potential proatherogenic lipoprotein[J].Arch Biochem Biophys,2006,445(2):245-255.
  • 8Bekesi G,Heinle H,Kakucs R,et al.Effect of inhibitors of myeloperoxidase on the development of aortic atherosclerosis in an animal model[J].Exp Gerontol,2005,40(3):199-208.

二级参考文献38

  • 1[1]Ridker PM. High-sensitivity C-Reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation,2001,103:1813-1818.
  • 2[2]Pannitteri G, Marino B,Campa PP,et al. Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction.Am J Cardiol, 1997,80:623-625.
  • 3[3]Danesh J, Wheeler JG, Hirschfield GM,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med, 2004,350:1387-1397.
  • 4[4]Buffon A, Biasucci LM, Liuzzo G,et al. Widespread coronary inflammation in unstable angina. N Engl J Med,2002,347:5-12.
  • 5[5]Naruko T, Ueda M, Haze K,et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation,2002,106:2894-2900.
  • 6[6]Daugherty A, Dunn JL, Rateri DL,et al. Myeloperoxidase a catalyst for lipoprotein xidation is expressed in human atherosclerotic lesions. J Clin Invest, 1994,94:437-444.
  • 7[7]Thukkani AK, McHowat J, Hsu FF, et al. Identification of alphachloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation,2003,108:3128-3133.
  • 8[8]Heller JI, Crowley JR, Hazen SL, et al. P-hydroxyphenylacetaldehyde an aldehyde generated by myeloperoxidase modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. J Biol Chem,2000,275:9957-9962.
  • 9[9]Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med,2000,28:1717-1725.
  • 10[10]Podrez EA, Poliakov E, Shen Z,et al. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem,2002,277:38517-38523.

共引文献8

同被引文献66

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部